Verified peer comparison
Marker Therapeutics vs CRISPR Therapeutics Financial Comparison
Direct answer
Marker Therapeutics and CRISPR Therapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Marker Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Marker Therapeutics Revenue
- 3,546,669 USD
- CRISPR Therapeutics Revenue
- 3,510,000 USD
- Marker Therapeutics Operating income
- -12,890,426 USD
- CRISPR Therapeutics Operating income
- -568,318,000 USD